Aria Bioscience, a leading biotech firm in Singapore, has announced a collaboration with the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) to explore the potential of mitochondrial biologics in consumer healthcare. This partnership focuses on developing applications for skin rejuvenation and hair restoration, leveraging A*STAR’s research on cellular resilience and mitochondrial function.
The collaboration seeks to bridge the gap between aesthetics and clinical medicine by applying mitochondria-targeted science to manage skin and hair ageing. A*STAR IMCB researchers have identified key cellular mechanisms and developed methods to enhance mitochondrial performance, which are crucial for maintaining cellular energy and function.
Timothy Chen, Executive Director of Aria Bioscience, stated, “We are working closely with A*STAR IMCB to assess the translational potential of the technology through human safety and efficacy studies. Our short-term goal is to launch medical-grade serum for epidermal application within the next six months.” A*STAR’s patented technology aims to restore mitochondrial quality by delivering functional mitochondria to specific cell types, potentially rejuvenating skin and hair cells.
This innovative approach could lead to next-generation longevity interventions, addressing ageing at the cellular level. Enhanced mitochondrial function is expected to improve cellular repair and tissue maintenance, offering promising solutions for age-related changes in skin and hair.
